ISEE — IVERIC bio Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
- $5.51bn
- $5.01bn
Annual cashflow statement for IVERIC bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 63.1 | -58.9 | -84.5 | -115 | -185 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -108 | 9.12 | 8.79 | 12.4 | 26 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.13 | 1.09 | 9.52 | 3.5 | -4.72 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -41.9 | -48.5 | -66.1 | -98.6 | -164 |
| Capital Expenditures | 0 | — | — | -0.361 | -0.736 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.15 | -144 | 21.7 | -49.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | 0.15 | -144 | 21.3 | -50.3 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.14 | 42.8 | 151 | 272 | 429 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -35.8 | -5.5 | -59.3 | 195 | 215 |